News

Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
Weight-Loss Drugs Aren’t Really About Weight
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
Novo Nordisk announces CEO transition as share price slips
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
Instant View: Novo Nordisk CEO's surprise exit after setbacks in weight-loss market
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
STAT2d
Novo Nordisk strikes deal with Septerna to develop obesity pills
Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...
Why Weight-Loss Developer Stocks Tumbled on Tuesday
A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...
The Week4d
Mounjaro vs Wegovy: Which weight loss drug works best? New trial reveals the answer
Mounjaro, manufactured by US drugmaker, and Wegovy by Danish drugmaker Novo Nordisk, cause weight loss by suppressing the ...
Wellness companies eager to avoid WeightWatchers’ fate embrace weight-loss drugs
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...